Australia markets close in 54 minutes

Assembly Biosciences, Inc. (ASMB)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
13.27+0.80 (+6.42%)
At close: 04:00PM EDT
12.82 -0.45 (-3.39%)
After hours: 07:43PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 72.43M
Enterprise value -55.48M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.44
Price/book (mrq)1.76
Enterprise value/revenue -7.75
Enterprise value/EBITDA 0.86

Trading information

Stock price history

Beta (5Y monthly) 0.61
52-week change 36.33%
S&P500 52-week change 323.57%
52-week high 320.04
52-week low 37.68
50-day moving average 313.12
200-day moving average 311.27

Share statistics

Avg vol (3-month) 324.26k
Avg vol (10-day) 312.46k
Shares outstanding 55.48M
Implied shares outstanding 65.48M
Float 83.64M
% held by insiders 133.10%
% held by institutions 113.10%
Shares short (15 Apr 2024) 430.56k
Short ratio (15 Apr 2024) 41.45
Short % of float (15 Apr 2024) 40.88%
Short % of shares outstanding (15 Apr 2024) 40.56%
Shares short (prior month 15 Mar 2024) 460.23k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 312 Feb 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-175.22%

Management effectiveness

Return on assets (ttm)-33.87%
Return on equity (ttm)-98.95%

Income statement

Revenue (ttm)7.16M
Revenue per share (ttm)1.57
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -64.2M
Net income avi to common (ttm)-61.23M
Diluted EPS (ttm)-13.38
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)130.25M
Total cash per share (mrq)23.76
Total debt (mrq)2.34M
Total debt/equity (mrq)5.70%
Current ratio (mrq)3.41
Book value per share (mrq)7.50

Cash flow statement

Operating cash flow (ttm)22.74M
Levered free cash flow (ttm)-8.2M